Monohydrate of (1-{9-[4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-N-methylcarboxamide | Patent Number 08524883

US 08524883 B2
Application Number13333872
Publication NumberUS 20120165350 A1
Pendency1 year, 8 months, 17 days
Filled DateDec 21, 2011
Priority DateFeb 3, 2006
Publication DateJun 28, 2012
Expiration DateFeb 2, 2026
Inventor/ApplicantsJeff Zablocki
Elfatih Elzein
Travis Lemons
Robert Seemayer
ExaminesCRANE, LAWRENCE E
Art Unit1623
Technology Center1600
Assignments
Gilead Sciences
Current
Gilead Sciences
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
See the invalidated claims, subscribe to our Concierge Program.
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.